+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Entyvio"

Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034 - Product Thumbnail Image

Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034

  • Report
  • April 2024
  • 318 Pages
  • Global
From
Mesalazine Market by Product Form (Enemas, Granules, Rectal Foam), Route Of Administration (Oral, Rectal), Application, End-User, Distribution Channel - Global Forecast 2025-2030 - Product Thumbnail Image

Mesalazine Market by Product Form (Enemas, Granules, Rectal Foam), Route Of Administration (Oral, Rectal), Application, End-User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • March 2025
  • 181 Pages
  • Global
From
U.S. Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report by Type, Drug Class, Route Of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

U.S. Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report by Type, Drug Class, Route Of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • May 2024
  • 70 Pages
  • United States
From
Inflammatory bowel disease (IBD) - Market Insights, Epidemiology, and Market Forecast - 2030 - Product Thumbnail Image

Inflammatory bowel disease (IBD) - Market Insights, Epidemiology, and Market Forecast - 2030

  • Report
  • January 2022
  • 130 Pages
  • Global
From
Ulcerative Colitis (UC) - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Ulcerative Colitis (UC) - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • August 2023
  • 295 Pages
  • Global
From
ENTYVIO Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ENTYVIO Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Ulcerative Colitis Market - Product Thumbnail Image

Ulcerative Colitis Market

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Ulcerative Colitis Market Size, Share & Industry Trends Analysis Report By Molecule Type (Small Molecules and Biologics), By Disease Type, By Route of Administration, By Regional Outlook and Forecast, 2022 - 2028 - Product Thumbnail Image

Ulcerative Colitis Market Size, Share & Industry Trends Analysis Report By Molecule Type (Small Molecules and Biologics), By Disease Type, By Route of Administration, By Regional Outlook and Forecast, 2022 - 2028

  • Report
  • April 2022
  • 188 Pages
  • Global
From
Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027 - Product Thumbnail Image

Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027

  • Report
  • October 2021
  • 288 Pages
  • Global
From
Ulcerative Colitis (UC) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031 - Product Thumbnail Image

Ulcerative Colitis (UC) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031

  • Drug Pipelines
  • March 2023
  • 125 Pages
  • Global
From
  • 10 Results (Page 1 of 1)
Loading Indicator

Entyvio is a biologic drug used to treat gastrointestinal diseases such as ulcerative colitis and Crohn's disease. It is a monoclonal antibody that works by blocking a protein called integrin alpha4beta7, which is involved in the inflammatory process. Entyvio is administered intravenously and is approved for use in adults and children. It is used to reduce symptoms and improve quality of life for those suffering from gastrointestinal diseases. Entyvio is part of a larger market of gastrointestinal drugs, which includes other biologics, immunomodulators, and corticosteroids. These drugs are used to treat a variety of gastrointestinal diseases, including inflammatory bowel disease, irritable bowel syndrome, and gastroesophageal reflux disease. Some companies in the Entyvio market include Takeda Pharmaceuticals, Janssen Biotech, AbbVie, and Pfizer. Show Less Read more